Ameriprise’s DICE Therapeutics, Inc. Common Stock DICE Stock Holding History

Ameriprise’s Portfolio DICE Stock Details DICE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-36,775	Closed	-$1.71M	–	4017
2023 Q2	$1.71M	Buy	+36,775	New	+$1.27M	﹤0.01%	2949

Ameriprise's DICE Position: Q3 2023 in Review

Ameriprise sold out of DICE Therapeutics, Inc. Common Stock (DICE) in Q3 2023, closing a stake of 36,775 shares — an estimated $1.71M sold.

Ameriprise first reported a position in DICE in Q2 2023 and held it in 1 quarter. The position peaked at $1.71M in Q2 2023. 0 funds tracked by Wall St. Rank hold DICE as of Q3 2023.

Ameriprise reported no remaining DICE Therapeutics, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
Ameriprise sold 36,775 DICE Therapeutics, Inc. Common Stock shares in Q3 2023, an estimated $1.71M.
Ameriprise first reported a position in DICE Therapeutics, Inc. Common Stock in Q2 2023 and held it in 1 quarter.
Ameriprise's DICE Therapeutics, Inc. Common Stock position peaked at $1.71M in Q2 2023.
0 funds tracked by Wall St. Rank held DICE Therapeutics, Inc. Common Stock as of Q3 2023.

Based on Ameriprise's 13F filing for Q3 2023, filed 14 Nov 2023.